Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001895556 | SCV002154556 | likely benign | Bardet-Biedl syndrome | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005016739 | SCV005644037 | uncertain significance | Bardet-Biedl syndrome 2; Retinitis pigmentosa 74 | 2024-03-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004538577 | SCV004709072 | likely benign | BBS2-related disorder | 2023-12-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |